Sharon Shacham

Companies

• Nasus Pharma LtdBoard member Mar 27, 2026 to now¹
• Acrivon Therapeutics, Inc.Board member Nov 9, 2022 to now²
• Karyopharm Therapeutics Inc.C.S.O & Pres. of Res & Develop Nov 5, 2013 to Mar 31, 2022³
• Karyopharm Therapeutics Inc.President Jun 19, 2014 to Mar 23, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKaryopharm Therapeutics Inc. KPTI1,671,888 shares⁵$586.8K at $0.35Mar 31, 2022
• ATAcrivon Therapeutics, Inc. ACRV9,366 shares⁶$15.4K at $1.64May 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 18, 2026Granted 9,366 shares of Acrivon Therapeutics, Inc.⁶
• Mar 29, 2022Granted 60,000 shares of Karyopharm Therapeutics Inc.⁵
• Feb 28, 2022Sold 6,226 shares at $10.24 of Karyopharm Therapeutics Inc.⁷
• Feb 28, 2022Granted 21,000 shares of Karyopharm Therapeutics Inc.⁷
• Feb 28, 2022Sold 6,226 shares at $10.24 of Karyopharm Therapeutics Inc.⁷
• Feb 17, 2022Sold 9,079 shares at $12.12 of Karyopharm Therapeutics Inc.⁸
• Feb 17, 2022Sold 9,088 shares at $12.12 of Karyopharm Therapeutics Inc.⁸
• Feb 7, 2022Sold 6,764 shares at $9.86 of Karyopharm Therapeutics Inc.⁹
• Feb 7, 2022Sold 6,707 shares at $9.86 of Karyopharm Therapeutics Inc.⁹